SanBio Company Limited
4592・Growth Market・Pharmaceuticals
SanBio Company Limited4592
Recent Disclosures
| Date | Type | Title |
|---|---|---|
| 2026-06-16 | Other | [Delayed]Notice Concerning Recording of Non-operating Income and Deferred Income Taxes |
| 2026-06-15 | Other | Consolidated Financial Results for the Three Months Ended April 30, 2026[Japanese GAAP] |
| 2026-06-15 | Earnings Report | 2027年１月期 第１四半期決算短信〔日本基準〕（連結） |
| 2026-06-15 | Other | 営業外収益及び法人税等調整額の計上に関するお知らせ |
| 2026-06-01 | Other | [Delayed]Notice Regarding the Launch of AKUUGO(R), a New Treatment Option for Chronic Motor Paralysis Following Traumatic Brain Injury |
| 2026-05-25 | Other | [Delayed]Notice Regarding NHI Price Listing of AKUUGO(R) Suspension for Intracranial Implantation |
| 2026-05-21 | Other | 外傷性脳損傷に伴う慢性期の運動麻痺に新たな治療選択肢「アクーゴ(R)脳内移植用注」発売のお知らせ |
| 2026-05-21 | Other | 「外傷性脳損傷に伴う慢性期の運動麻痺に新たな治療選択肢「アクーゴ(R)脳内移植用注」発売のお知らせ」の一部修正について |
| 2026-05-20 | Other | アクーゴ(R)脳内移植用注の薬価基準収載のお知らせ |
| 2026-05-19 | Other | [Delayed]Notice Concerning Chuikyo Approval of Proposed NHI Price for AKUUGO(R) and Revision of Consolidated Earnings Forecast for FY Ending Jan. 2027 |